Given its multifaceted immune-regulatory role, KRT17 and other stress keratins emerge as a therapeutic target in chronic inflammatory skin diseases such as psoriasis, atopic dermatitis, cutaneous lupus erythematosus (CLE), and hidradenitis suppurativa (HS). Here, KRT17 is linked to histiocytic sarcoma.